Health Care Technology

HEALTHLYNKED CORP

HEALTHLYNKED CORP released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 1.367M, actual EPS USD -1

HEALTHLYNKED CORP released FY2024 Q2 earnings on August 14, 2025 (EST) with actual revenue of USD 795.08K and EPS of USD -1

HEALTHLYNKED CORP released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 592.36K, actual EPS USD -0.2486

HEALTHLYNKED CORP released FY2024 Semi-Annual earnings on August 14, 2025 (EST) with actual revenue of USD 1.799 M and EPS of USD -1.0415

HEALTHLYNKED CORP released FY2025 Q1 earnings on May 15, 2025 (EST) with actual revenue of USD 774.21K and EPS of USD -0.3727

HealthLynked Corp released FY2024 Q1 earnings on May 15, 2025 (EST) with actual revenue of USD 1.004M and EPS of USD -0.4947

HealthLynked Corp released FY2023 Q4 earnings on March 31, 2025 (EST) with actual revenue of USD 931.21K and EPS of USD -0.4779

HEALTHLYNKED CORP released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 618.93K, actual EPS USD -0.4364

HEALTHLYNKED CORP released FY2023 earnings on March 31 (EST), actual revenue USD 5.722 M, actual EPS USD -0.385

HEALTHLYNKED CORP released FY2024 Annual Earnings on March 31 (EST), actual revenue USD 3.008M, actual EPS USD -2.1778

HealthLynked Corp released FY2024 Q3 earnings on November 14 (EST), actual revenue USD 590.12K, actual EPS USD -1

HealthLynked Corp released FY2024 9 Months Earnings on November 14, 2024 (EST) with actual revenue of USD 2.389M and EPS of USD -2.4947

HEALTHLYNKED CORP released FY2023 Q3 earnings on November 14 (EST), actual revenue USD 1.333 M, actual EPS USD -0.0658

HEALTHLYNKED CORP released FY2023 Semi-Annual Earnings on August 14, 2024 (EST), actual revenue USD 3.459M, actual EPS USD 0.0118

HEALTHLYNKED CORP released FY2023 Q2 earnings on August 14, 2024 (EST) with actual revenue of USD 1.703M and EPS of USD -0.3862

< 1B

1B - 5B

5B - 10B

10B - 50B

50B - 100B

100B - 500B

500B - 1T

≥ 1T

Market Value

Total Assets

< 100M

100M - 500M

500M - 1B

≥ 100B

Revenue

0 - 50M

50M - 100M

≥ 10B

Profits

< 0%

0% - 5%

5% - 10%

10 - 15%

15% - 20%

20 - 25%

25% - 30%

>= 30%

ROE(TTM)

= 0%

0% - 1%

1% - 3%

3% - 5%

5% - 8%

8% - 10%

>= 10%

Dividend Yield

0% - 10%

10% - 15%

20% - 30%

30% - 40%

40% - 50%

>= 50%

Net Profit Margin

0 - 0.05

0.05 - 0.1

0.1 - 0.2

0.2 - 0.4

0.4 - 0.6

0.6 - 0.8

0.8 - 1

>= 1

Asset Turnover

< 1.5

1.5 - 2

2 - 3

3 - 5

5 - 10

10 - 15

15 - 20

>= 20

Equity Multiplier

< 10%

10% - 30%

30% - 50%

50% - 70%

70 - 80%

80% - 90%

90% - 95%

>= 95%

Debt Ratio

Algorhythm

Jiade

Moolec Science SA

Nuveen Real Asset Income and Growth Fund

Atomera

AIM ImmunoTech

Splash Beverage

GraniteShares 2x Long RIVN Daily ETF

Founder

Vivopower

Veeva Systems -CL

Doximity

Waystar

Phreesia

HealthStream

OptimizeRx

LifeMD

CareCloud

Forian

Certara

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

HLYK

HLYKD

NAPLES, Fla., Oct. 24, 2025 ( GLOBE NEWSWIRE ) -- via IBN -- HealthLynked Corp. ( OTCQB:HLYK ) , a leading provider of healthcare technology and patient engagement solutions, today announced the launch of its new MedOfficeDirect e-commerce platform built on Shopify, now operating under the URL ...

Benzinga

HealthLynked Corp.

HealthLynked Launches New MedOfficeDirect Shopify Platform at DiscountOnlineMedicalSupplies.com with Improved Performance and Lower Prices

LB filings

HEALTHLYNKED CORP | 10-Q: FY2024 Q3 Revenue: USD 590.12 K

HealthLynked Corporation has completed a reverse stock split to reduce outstanding shares, aiming to strengthen its capital structure and improve market positioning. This move is intended to increase the per-share price, enhance visibility, and attract a broader range of investors. The company is also advancing its AI-driven healthcare platform and expanding its intellectual property portfolio to support future growth.

Reuters

HealthLynked Corp Completes Reverse Stock Split to Boost Market Position and Investor Appeal

HealthLynked Corp. has completed a reverse stock split to strengthen its market position and enhance shareholder value. This strategic move aims to improve capital structure and attract institutional investors by increasing the per-share price without diluting ownership. The company is also scaling its AI-driven healthcare platform and expanding its intellectual property portfolio. CEO Michael Dent emphasizes the commitment to long-term growth and the potential for substantial recurring revenue through partnerships with major insurance carriers.

StockTitan

Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform | HLYK Stock News

HealthLynked Corp. | 10-Q: FY2025 Q2 Revenue: USD 592.36 K

Healthlynked Corp :HEALTHLYNKED LAUNCHES NATIONAL INITIATIVE TO ACCELERATE MEDICAL DISCOVERY THROUGH PATIENT PARTICIPATION AND STRATEGIC PHARMA PARTNERSHIPS

HealthLynked Launches National Drive to Boost Medical Discovery via Patient & Pharma Partnerships

HealthLynked Corp. has launched a new Enterprise Healthcare Solutions Website and upgraded its provider directory to enhance its role in the healthcare market. The website serves as a platform for commercial partners, offering tailored solutions for insurance carriers, pharmaceutical companies, and healthcare networks. The upgraded provider directory improves user experience with faster performance and localized provider suggestions, empowering patients in their healthcare choices. CEO Dr. Michael Dent emphasized the company's commitment to innovation and improving healthcare access and coordination.

HealthLynked Launches New Enterprise Healthcare Solutions Website and Upgraded Provider Directory to Expand Strategic Value Across the Healthcare Market | HLYK Stock News

HealthLynked Corporation has appointed Andrew Mavliev as Chief Technology and Product Officer to enhance its direct-to-consumer healthcare innovations. Mavliev, with over 15 years of experience in technology strategy and product development, previously served as the founding CTO of Aram Meem LLC. HealthLynked aims to improve patient engagement through its AI-powered digital healthcare ecosystem. This announcement was made on June 30, 2025.

Definitive Healthcare

Unitedhealth

HealthLynked Corporation Appoints Andrew Mavliev as Chief Technology and Product Officer to Boost Direct-to-Consumer Healthcare Innovations

HealthLynked Corporation has partnered with Endlink to improve interoperability in hospital systems and electronic medical records (EMRs). This collaboration aims to enhance patient care coordination by integrating HealthLynked’s secure patient records and AI insights into Endlink’s platform, which serves over 300,000 members. The partnership is expected to drive significant revenue growth and make healthcare more connected and accessible.

HealthLynked Corporation Partners with Endlink to Enhance EMR and Hospital System Integration

HealthLynked Corp. | 10-Q: FY2025 Q1 Revenue: USD 774.21 K

HealthLynked Corp. has released its Annual Shareholder Letter, detailing significant product developments and strategic priorities for 2024. Key highlights include the launch of ARI, an AI healthcare guidance tool, nationwide telemedicine expansion, a new concierge service, and a discount prescription drug program. CEO Dr. Dent emphasizes the company's commitment to growth through innovative marketing and strategic partnerships, aiming to enhance patient care and accessibility. The full letter is available on the HealthLynked website for shareholders and interested parties.

GlobeNewswire

C3.AI

HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future

HealthLynked Corp. has appointed Jeremy Daniel as its new Chief Financial Officer, effective immediately. Daniel brings extensive experience, having previously served as CFO for Regenerative Medicine Solutions and as controller for Omnicare. He is recognized for his expertise in managing financial systems in accordance with GAAP and SEC regulations.

rttnews

HealthLynked Appoints Jeremy Daniel As Chief Financial Officer

HEALTHLYNKED CORP(HLYKD.US)

Financial Score

Valuation analysis

Institutional View & Shareholder

Analyst Ratings

HealthLynked Launches New MedOfficeDirect Shopify Platform at DiscountOnlineMedicalSupplies.com with Improved Performance and Lower Prices

HEALTHLYNKED CORP | 10-Q: FY2024 Q3 Revenue: USD 590.12 K

HealthLynked Corp Completes Reverse Stock Split to Boost Market Position and Investor Appeal

Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform | HLYK Stock News

HealthLynked Corp. | 10-Q: FY2025 Q2 Revenue: USD 592.36 K